Product Information
PITAVASTATIN 4 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.1362 per EA under NDC 31722087790. Its NADAC has been published 107 times since Aug 7, 2024.
FDA first approved this application on Apr 30, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4.18 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722087790
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PITAVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA205977FDA Approved
4/30/2024
TE Code
AB
On Market Since
4/30/2024
Pharmacological Classes
Price Statistics
The NADAC for PITAVASTATIN 4 MG TABLET has been published 107 times since Aug 7, 2024, and over the history we have for it it has declined 29.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1362 per EA |
|---|---|
| All-time high | $2.0242 (Sep 11, 2024) |
| All-time low | $1.1362 (Aug 19, 2026) |
| 52-week high | $1.5488 |
| 52-week low | $1.1362 |
| Median price | $1.5385 |
| Average price | $1.5451 |
| Largest weekly change | +24.9% (Aug 21, 2024) |
| Weeks tracked | 107 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PITAVASTATIN 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 4 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.1362 per EA (NDC 31722087790), effective Aug 19, 2026.
How has the price of PITAVASTATIN 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PITAVASTATIN 4 MG TABLET has declined 29.9%. It has been tracked across 107 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for PITAVASTATIN 4 MG TABLET?
Since Aug 7, 2024, the NADAC for PITAVASTATIN 4 MG TABLET has ranged from a low of $1.1362 (Aug 19, 2026) to a high of $2.0242 (Sep 11, 2024), with a median of $1.5385 per EA.
Are there cheaper alternatives to PITAVASTATIN 4 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PITAVASTATIN 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PITAVASTATIN 4 MG TABLET?
PITAVASTATIN 4 MG TABLET (NDC 31722087790) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.